Clicky

Monday, November 2, 2026

Breaking News

Latest SEC filings as they come in

Warberg Asset Management Reports $755 Million in Holdings
Latest

Warberg Asset Management Reports $755 Million in Holdings

Warberg Asset Management LLC's latest 13F-HR reveals $755 million in investments, showcasing its commitment to transparency in asset management.

Delos Meridian Corp. files new offering for $500,000

Franklin California Tax Free Trust Updates Fund Prospectus

Pasqal Holding SA Registers Shares for Employee Incentive Plans

In Focus

Inovio Pharmaceuticals secures FDA approval for VOCERYQ

Xcel Energy proposes $2 billion convertible notes offering

uniQure's ifezuntirgene inilparvovec BLA Accepted by FDA

Across the Market

Cipher Digital Announces Strong Q3 Results, Expands Lease Revenue

Flowco Holdings Inc. files 8-K detailing financial updates

Lumentum Reports Strong Q1 Results, Projects Continued Growth

Latest Filings

1

Greece Signs Deal for Six Embraer KC-390 Aircraft

2

Boardwalk Pipeline Partners Reports Q3 2026 Financial Results

3

Fort Technology Announces Voluntary Delisting from TSX Venture

4

Graf Global Corp. to Merge with BIG3, First Public Sports League

5

Graf Global Corp. advances merger with BIG3 HoldCo LLC

More Breaking News News

Diageo reports total voting rights for October 2026

Diageo PLC discloses total voting rights as of October 1, 2026, ensuring compliance with transparency regulations in the beverages industry.

TAT Technologies Reports Record Third Quarter Results

TAT Technologies Ltd. announces record Q3 2026 results, showcasing strong revenue growth and profitability amid rising demand in the aerospace sector.

Shell plc executive sells 33,000 shares in company

Shell plc's Andrew Smith sells 33,000 shares, totaling €1.6 million, highlighting significant internal transactions in the crude petroleum sector.

Krystal Biotech reports Q3 results, advances product pipeline

Krystal Biotech, Inc. announces its Q3 results, showcasing advancements in its product pipeline within the biological products sector.

Seaport Therapeutics reports Q3 results, highlights growth plans

Seaport Therapeutics, Inc. releases its Q3 financial results, showcasing strategic developments in the pharmaceutical preparations sector.

Krystal Biotech announces strong Q3 results, share buyback

Krystal Biotech reports $127.3M in Q3 revenue and launches $400M share repurchase program, signaling confidence in growth and market expansion.

TripAdvisor sells TheFork to American Express for $700 million

TripAdvisor sells its restaurant reservation platform TheFork to American Express for $700 million, marking a strategic shift in its business focus.

ParaZero Secures Fourth Order from European Defense Company

ParaZero Technologies receives a significant order from a Tier-1 European defense company, enhancing its position in the defense industry.

Axsome Therapeutics reports Q3 2026 financial results

Axsome Therapeutics, Inc. announces its Q3 2026 financial results and operational updates, signaling ongoing commitment to innovation in pharmaceuticals.

Naqi Logix extends convertible promissory notes to executives

Naqi Logix Inc. announces the extension of convertible promissory notes to key executives, securing additional funding for operations.

Microsoft seeks to raise $25 billion through debt offering

Microsoft Corp files for a $25 billion debt offering, including floating and fixed-rate notes, to enhance financial flexibility and support investments.

Tiziana Life Sciences Reports Positive Phase 2a Trial Results

Tiziana Life Sciences announces positive results from its Phase 2a INFORM-MS trial for intranasal foralumab, showing significant improvements in MS patients.

Can-Fite BioPharma Secures Eurasian Patent for Piclidenoson

Can-Fite BioPharma has announced a patent allowance for Piclidenoson, enhancing its position in the pharmaceutical market for rare diseases.

Kamada to Announce Third Quarter Financial Results on Nov. 9

Kamada Ltd. will release its Q3 financial results on November 9, 2026, with a conference call to discuss the outcomes. Watch for industry impacts.

TAT Technologies Reports Strong Q3 2026 Financial Results

TAT Technologies Ltd. announces significant revenue and net income growth in Q3 2026, indicating strong performance in the aircraft engines sector.

RedHill Biopharma confirms RHB-204 efficacy for Crohn's disease

RedHill Biopharma Ltd. confirms RHB-204's efficacy against Crohn's disease, enhancing treatment options in the pharmaceutical industry.

Marriott International Reports Third Quarter 2026 Results

Marriott International reports strong Q3 2026 results with RevPAR growth, showcasing resilience in the Hotels & Motels industry.

Tempus AI Reports Q3 Results, Shows Revenue Growth

Tempus AI, Inc. announces Q3 financial results, highlighting significant revenue growth and strategic partnerships in the computer programming sector.

Tempus AI, Inc. Reports Q3 2026 Financial Results

Tempus AI, Inc. announces its financial results for Q3 2026, showcasing growth and potential impacts on the tech industry.

Eton Pharmaceuticals Launches ET-900 Program for Spasms

Eton Pharmaceuticals announces ET-900, a new program for treating infantile and epileptic spasms, in collaboration with Baylor College of Medicine.

Information Services Group reports Q3 2026 earnings results

Information Services Group Inc. releases its Q3 2026 earnings, discussing financial performance and future strategies in the management consulting services sector.

Vertical Data Inc. estimates Q3 revenue, plans private placement

Vertical Data Inc. projects Q3 2026 revenue of $0.4-$0.5 million and plans a $4.2 million private placement, signaling growth in management consulting.

Seaport Therapeutics Reports Q3 2026 Financial Results

Seaport Therapeutics, Inc. announces its financial results for Q3 2026, impacting the pharmaceutical preparations industry and influencing stakeholder decisions.

Alpine Income Property Trust Completes $117.3M Acquisition

Alpine Income Property Trust, Inc. has acquired a 13-property industrial portfolio for $117.3 million, enhancing its market position in the real estate sector.

More stories

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →